Nomogram for Estimating Overall Survival in Patients With Metastatic Pancreatic Cancer

OBJECTIVES: This analysis investigated nomogram use to evaluate metastatic pancreatic cancer prognosis. METHODS: Thirty-four baseline factors were examined in the Metastatic Pancreatic Adenocarcinoma Clinical Trial (MPACT) (nab-paclitaxel plus gemcitabine vs gemcitabine) data set. Factors significan...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Pancreas
Main Authors: Goldstein, David, Von Hoff, Daniel D., Chiorean, E. Gabriela, Reni, Michele, Tabernero, Josep, Ramanathan, Ramesh K., Botteman, Marc, Aly, Abdalla, Margunato-Debay, Sandra, Lu, Brian, Louis, Chrystal U., McGovern, Desmond, Lee, Chee Khoon
Formato: Artigo
Idioma:Inglês
Publicado em: Lippincott Williams & Wilkins 2020
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7314499/
https://ncbi.nlm.nih.gov/pubmed/32541630
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MPA.0000000000001563
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados